Connect with us
DAPA Banner

Business

TSA Security Wait Times Surge at Major U.S. Airports Amid Partial Government Shutdown and Staffing Challenges

Published

on

Telstra

Travelers at several major U.S. airports faced significantly longer **Transportation Security Administration** (TSA) security lines in mid-March 2026, with wait times reaching up to three hours at some checkpoints. The delays, reported across hubs like Atlanta, Houston and New Orleans, stem from a partial government shutdown affecting federal staffing, compounded by high travel volumes and occasional weather disruptions.

Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight

CNN has been tracking real-time TSA wait times at 15 key airports, including Atlanta (ATL), New York (JFK and LaGuardia), Los Angeles (LAX), Miami (MIA), Dallas-Fort Worth (DFW), Denver (DEN) and others. As of March 18, 2026, fluctuations were evident: Hartsfield-Jackson Atlanta International Airport, the nation’s busiest, saw main checkpoint waits drop to around 20 minutes by late afternoon Tuesday after peaking at over 90 minutes earlier in the day for international terminals and 30-40 minutes for domestic. Reports from March 17 indicated morning spikes to three hours at ATL.

Houston’s airports also experienced extended delays. William P. Hobby (HOU) reported up to 3.5 hours over the weekend, while George Bush Intercontinental (IAH) hovered near two hours. New Orleans Louis Armstrong International (MSY) saw lines up to two hours, and Fort Lauderdale-Hollywood (FLL) had reports of lines stretching out the door. Charlotte Douglas (CLT) and Austin-Bergstrom (AUS) noted longer-than-normal waits, with some Chicago O’Hare (ORD) checkpoints hitting hour-long delays.

In contrast, other major hubs showed shorter lines during off-peak periods. Los Angeles International (LAX) reported waits as low as 2-6 minutes on March 17, and JFK in New York had minimal delays of just a few minutes Tuesday morning despite weekend crowds. Dallas-Fort Worth checkpoints generally stayed under 20 minutes in most terminals.

The TSA does not maintain a single nationwide real-time dashboard due to the decentralized nature of checkpoint data. Instead, the agency directs travelers to the **MyTSA mobile app**, available on iOS and Android. The app provides crowd-sourced and historical wait time estimates in 15-minute intervals, allowing users to check current conditions or forecast for specific days and times. It also includes weather updates, delay information and tips for security screening. During the partial shutdown, however, some data may rely more heavily on historical trends if live inputs lag.

Advertisement

Many airports publish their own live or near-real-time wait times on official websites, offering checkpoint-specific details:

– **Hartsfield-Jackson Atlanta (ATL)**: Real-time updates at atl.com/times show varying times by terminal and checkpoint.

– **Miami International (MIA)**: miami-airport.com/tsa-waittimes.asp lists general, priority and TSA PreCheck lanes, with recent samples showing 3-14 minutes in some checkpoints.

– **Dallas-Fort Worth (DFW)**: dfwairport.com/security provides per-terminal estimates.
– **Los Angeles (LAX)**: flylax.com/wait-times offers quick checks.

Advertisement

– **Orlando (MCO)**: Recent Florida reports showed 14-44 minutes depending on gates.

– Other sites like Reagan National (DCA), Baltimore-Washington (BWI) and Charlotte (CLT) feature dedicated wait-time pages or PreCheck schedules.

The current disruptions highlight ongoing TSA staffing pressures. A partial government shutdown has left many TSA employees working without full pay, prompting call-outs and lane closures — including some dedicated TSA PreCheck lanes at affected airports. Over half of Houston-area TSA staff reportedly called out in recent days, exacerbating lines. Private-contractor screening at select airports has insulated those locations from federal shutdown impacts.

Travelers are advised to arrive earlier than standard recommendations. Many airports now suggest three hours for domestic flights and longer for international, especially during peak periods. Enrolling in TSA PreCheck, CLEAR or other expedited programs can significantly reduce wait times where available. The MyTSA app and airport websites remain the best tools for planning, though data accuracy may vary amid operational challenges.

Advertisement

Spring break travel, combined with the shutdown, has amplified congestion at Sun Belt hubs like Atlanta, Florida airports and Texas facilities. Florida-specific updates from March 17 showed manageable waits at many smaller airports (e.g., 3-19 minutes at Northwest Florida Beaches), but major ones like Orlando and Miami experienced moderate increases.

Experts urge checking multiple sources before heading to the airport, as conditions can change rapidly due to staffing, weather or sudden volume surges. The TSA encourages using the app to report wait times if at the checkpoint, helping crowdsource better data for others.

As the partial shutdown persists, air travelers should monitor updates closely. The situation underscores the vulnerability of security operations to federal funding issues, with potential for continued variability until resolved.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Form 13G Zeta Network Group For: 18 March

Published

on


Form 13G Zeta Network Group For: 18 March

Continue Reading

Business

Selling Sheffield Wednesday

Published

on

Selling Sheffield Wednesday

BBC Sport looks at one of England’s most famous football clubs’ fight for survival.

Continue Reading

Business

Bentley workers 'shocked and angry' at job cuts

Published

on

Bentley workers 'shocked and angry' at job cuts

A union says the announcement came as a blow to employees with up to 275 positions at risk.

Continue Reading

Business

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

Published

on

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.

Kyle Grillot | Bloomberg | Getty Images

Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots.

Advertisement

The FDA approved the pill, Icotyde, to treat moderate to severe plaque psoriasis, an autoimmune condition that causes rough patches of skin. Patients typically start treatment with topical medications.

If those don’t work, they advance to pills or shots. J&J sees Icotyde becoming the first-line systematic treatment for psoriasis, in between topicals and shots.

Drugmakers have been developing more advanced medicines than standard topicals, turning psoriasis into a highly competitive space. Icotyde targets the same IL-23 receptor as best-selling shots like J&J’s Tremfya and AbbVie‘s Skyrizi, giving patients an oral alternative to some of the most advanced — and most expensive — drugs on the market.

“To be able to to be able to have something that is relatively simple, that offers that level of clearance, trusted safety profile, and in a simple pill, we think is going to be revolutionary,” said Jennifer Taubert, chairman of J&J Innovative Medicine.

Advertisement

J&J estimates about 8 million people in the U.S. have plaque psoriasis, and that 75% of people don’t advance from topicals to shots because of reasons like fearing needles. Taubert sees Icotyde appealing to those patients.

“We believe having the type of profile that Icotyde has in a simple, once-daily oral pill, we think it’s going to be an absolute game changer for patients,” Taubert said.

J&J hasn’t announced how much Icotyde will cost beyond saying the company will help people pay for the medicine. Rival shots Tremfya and Skyrizi cost around $100,000 a year.

J&J sees peak annual sales of Icotyde exceeding $5 billion once it’s approved for other autoimmune conditions. It’s testing the drug for psoriatic arthritis, ulcerative colitis and Crohn’s disease.

Advertisement

Shares of J&J slid one-quarter of a percent Wednesday while shares of Skyrizi-maker AbbVie fell more than 4%. Protagonist Therapeutics, a biotech company that developed Icotyde with J&J, was trading about flat.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Brightstar Lottery stock hits 52-week low at 12.6 USD

Published

on


Brightstar Lottery stock hits 52-week low at 12.6 USD

Continue Reading

Business

Stocks Can’t Recover While Oil Prices Surge. Why the Fed’s Unlikely to Help.

Published

on

Stocks Can’t Recover While Oil Prices Surge. Why the Fed’s Unlikely to Help.

Stocks Can’t Recover While Oil Prices Surge. Why the Fed’s Unlikely to Help.

Continue Reading

Business

US holds interest rates as Iran war triggers oil shock

Published

on

US holds interest rates as Iran war triggers oil shock

The US central bank is moving cautiously, despite pressure from the president to cut interest rates.

Continue Reading

Business

Big Tech’s Huge Conglomerate Premium

Published

on

Big Tech’s Huge Conglomerate Premium

Big Tech’s Huge Conglomerate Premium

Continue Reading

Business

Datassential reveals top emerging foodservice chains

Published

on

Datassential reveals top emerging foodservice chains

Top chains specialized in focused concepts and tapped into trending flavors.

Continue Reading

Business

Hewlett Packard Enterprise's AI Story Moved To The Network Layer

Published

on

Hewlett Packard Enterprise's AI Story Moved To The Network Layer

Hewlett Packard Enterprise's AI Story Moved To The Network Layer

Continue Reading

Trending

Copyright © 2025